Delivery Order SPE2DB24D2003-SPE2DB25FXMQ9
Award Date 9/12/25
Potential Completion Date 9/15/25
Potential Value $1.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $2,744.54 to AmerisourceBergen Drug Corp for the supply of Exforge HCT 10-160-12.5 mg tablets (30-count bottles) on September 3, 2025, with completion scheduled for September 4, 2025. This competitively awarded, firm fixed-price delivery order was placed without set-aside designation and represents a single pharmaceutical supply transaction under the company's existing contract vehicle. AmerisourceBergen Drug Corp, a major...
- The Defense Logistics Agency awarded a delivery order valued at $1,171.24 to AmerisourceBergen Drug Corp for Exforge HCT 10-160-12.5 mg tablets (30-count supply) on September 10, 2025, with completion expected by September 11, 2025. This firm fixed-price delivery order represents a non-competitive set-aside procurement and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $1,679.83 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Exforge 5-320 mg tablets (30-count). This firm fixed-price contract, with an ultimate completion date of July 29, 2025, represents a non-competitive set-aside delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's corporate headquarters in...
- The Defense Logistics Agency awarded a $16,889.00 delivery order to AmerisourceBergen Drug Corp for 30-count tablets of Exforge 10-320 mg, a combination antihypertensive medication. This competitively awarded, firm fixed-price contract was executed on July 23, 2025, with an ultimate completion date of July 24, 2025, and represents a child delivery order under a larger indefinite delivery contract vehicle. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Exforge 10-320 mg tablets (30-count units) under a firm fixed price contract valued at $2,254.53. The award was made on August 5, 2025, with an ultimate completion date of August 6, 2025, and represents a non-set-aside competitive award. Performance will take place at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $2,001.95 to AmerisourceBergen Drug Corp for Exforge 10-320 mg tablets (30-count) on August 27, 2025, with an ultimate completion date of August 28, 2025. This competitively awarded, firm fixed-price contract is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Exforge HCT 10-160-25 mg tablets. The $1,464.78 firm fixed-price contract has a June 2024 completion date and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
- The Defense Logistics Agency awarded a delivery order valued at $6,724.20 to AmerisourceBergen Drug Corp for EXFORGE HCT 10-160-25 mg tablets (30-count supply) on September 12, 2025, with an ultimate completion date of September 15, 2025. This delivery order represents a firm fixed price transaction under a non-set-aside competitive procurement and will be performed at the vendor's location in Conshohocken, Pennsylvania. EXFORGE HCT is a combination hypertension medication, reflecting the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,258.65 firm fixed-price delivery order (SPE2DB20D3101|SPE2DB23FQUV5) is for 30-count packages of the medication Exforge HCT 10-320-25 mg tablets. The contract has an ultimate completion date of November 16, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- The U.S. government agency Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract, valued at $6,862.00, is to provide pharmaceutical products including the medication Exforge HCT 5-160-12.5 mg tablets. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp, with a potential value of...